Executive Team

 
Karl Beutner.jpg

Karl Beutner, MD, PhD

Chief Executive Officer

Nick Eliovits.jpg

Nichola (Nick) Eliovits

CHIEF Financial OFFICER

Max N. Dawson.jpg

Max N. Dawson

Chief OPERATING Officer

Emma_Taylor_Headshot.jpg

Emma Taylor, MD

Advisor, Dermatology

 

Board of Directors

 

Daniel Yadegar, M.D.
Managing Partner at Double Point Ventures.

Karl Beutner, M.D., Ph.D.
Co-founder & CEO at DermBiont; previously CMO at Anacor (acquired by Pfizer for $5.2 billion) and CMO at Dow Pharmaceutical Sciences (acquired by Valeant).

Nichola Eliovits
Co-founder & CFO at DermBiont; Managing Partner at Olive Tree Capital.

Steven Basta, Director​
CEO at Phathom Pharmaceuticals; previously CEO of BioForm Medical (acquired by Merz Aesthetics), Merz Aesthetics, Mahana Therapeutics, Menlo Therapeutics, and AlterG Inc.

Wilder Ramsey, Director​
Co-founder & Partner at Toba Capital​.